A Comparative Randomized, Double-blind, Double-Dummy, Multicenter Study of the Efficacy and Safety of Miconazole Lauriad 50mg Administered Once a Day and Mycelex Troches (Clotrimazole 10mg) Administered Five Times a Day in the Treatment of Oropharyngeal Candidiasis in Immunocompromised Patients

Trial Profile

A Comparative Randomized, Double-blind, Double-Dummy, Multicenter Study of the Efficacy and Safety of Miconazole Lauriad 50mg Administered Once a Day and Mycelex Troches (Clotrimazole 10mg) Administered Five Times a Day in the Treatment of Oropharyngeal Candidiasis in Immunocompromised Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Aug 2013

At a glance

  • Drugs Miconazole (Primary) ; Clotrimazole
  • Indications Oropharyngeal candidiasis
  • Focus Registrational; Therapeutic Use
  • Acronyms SMILES
  • Most Recent Events

    • 28 Aug 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT00390780).
    • 22 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top